Endonovo Therapeutics Inc. (ENDV) Expanding Commercialization of SofPulse Pain Management Solution as Alternative to Opioids
As the U.S. attempts to address its opioid crisis, the need for safe and effective pain management solutions is growing Endonovo Therapeutics is making significant progress toward commercializing its SofPulse® device that delivers pulsed electromagnetic frequencies for pain management Endonovo has completed clinical trials and is currently expanding commercialization of the device Several strategic appointments have also been made recently to strengthen the Endonovo team and the company’s clinical work Endonovo Therapeutics Inc. (OTCQB: ENDV) is putting a lot of effort into the commercialization of SofPulse®, the company’s Electroceutical® wearable therapeutic device for pain management. The non-invasive, safe solution delivers…